Agnikarma for the management of wart

A comparative study of Agnikarma by Rajat Shalaka versus Tamra Shalaka in the management of Charmakeel. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/057111

Enrollment

Registered

2023-08-31

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from Charmakeel will be taken. 2. Patients have no pre-existing serious medical condition. 3. Person currently taking no other medication.

Exclusion criteria

Exclusion criteria: 1. Age below 18 years and above 60 years 2. Any serious systemic disorders like Tuberculosis, Hypertesion, Diaetic melliatus etc 3. Pregnant women 4. Mentally sick patient 5. HIV, HBsAg, HCV Positive cases • Warts associated with other complication.

Design outcomes

Primary

Measure	Time frame
Decrease in size with relief in painTimepoint: 14 Days (with in two weeks)	—

Secondary

Measure	Time frame
Size of Charmakeel reduction with pain relief & resolution of all symptomsTimepoint: 21 to 28 Days (three weeks to four weeks)	—

Countries

India

Contacts

Public ContactDr Suman Yadav

Government P.G. Ayurvedic College and Hospital, Varanasi

yadavsuman06022073@gmail.com9451965767

Outcome results